108 related articles for article (PubMed ID: 19941076)
1. PCR-based methods for CDA K27Q and A70T genotyping: genotypes and alleles distribution in a central Italy population.
Carpi FM; Vincenzetti S; Micozzi D; Vita A; Napolioni V
Mol Biol Rep; 2010 Oct; 37(7):3363-8. PubMed ID: 19941076
[TBL] [Abstract][Full Text] [Related]
2. Rapid allele-specific PCR method for CDA 79A>C (K27Q) genotyping: a useful pharmacogenetic tool and world-wide polymorphism distribution.
Carpi FM; Xu J; Vincenzetti S; Vita A; Cai WM; Napolioni V
Clin Chim Acta; 2011 Nov; 412(23-24):2237-40. PubMed ID: 21884687
[TBL] [Abstract][Full Text] [Related]
3. Human cytidine deaminase: a biochemical characterization of its naturally occurring variants.
Micozzi D; Carpi FM; Pucciarelli S; Polzonetti V; Polidori P; Vilar S; Williams B; Costanzi S; Vincenzetti S
Int J Biol Macromol; 2014 Feb; 63():64-74. PubMed ID: 24183806
[TBL] [Abstract][Full Text] [Related]
4. [Single-nucleotide polymorphisms of the cytidine deaminase gene in childhood with acute leukemia and normal Chinese children].
Yue LJ; Chen XW; Li CR; Li CG; Shi HS; Zhang M
Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2007 Dec; 24(6):699-702. PubMed ID: 18067088
[TBL] [Abstract][Full Text] [Related]
5. [Study on the relationship between human cytidine deaminase gene polymorphisms and Ara-C sensitivity].
Chen XW; Yue LJ; Li CR; Li CG; Shi HS; Zhang M
Zhonghua Xue Ye Xue Za Zhi; 2008 Jul; 29(7):459-63. PubMed ID: 19035178
[TBL] [Abstract][Full Text] [Related]
6. CDA gene polymorphisms and enzyme activity: genotype-phenotype relationship in an Italian-Caucasian population.
Carpi FM; Vincenzetti S; Ubaldi J; Pucciarelli S; Polzonetti V; Micozzi D; Mignini F; Napolioni V
Pharmacogenomics; 2013 May; 14(7):769-81. PubMed ID: 23651026
[TBL] [Abstract][Full Text] [Related]
7. High-resolution melting analysis of sequence variations in the cytidine deaminase gene (CDA) in patients with cancer treated with gemcitabine.
Raynal C; Ciccolini J; Mercier C; Boyer JC; Polge A; Lallemant B; Mouzat K; Lumbroso S; Brouillet JP; Evrard A
Ther Drug Monit; 2010 Feb; 32(1):53-60. PubMed ID: 20010457
[TBL] [Abstract][Full Text] [Related]
8. The pharmacological advantage of prolonged dose rate gemcitabine is restricted to patients with variant alleles of cytidine deaminase c.79A>C.
Metharom E; Galettis P; Manners S; Jelinek M; Liauw W; de Souza PL; Hoskins JM; Links M
Asia Pac J Clin Oncol; 2011 Mar; 7(1):65-74. PubMed ID: 21332653
[TBL] [Abstract][Full Text] [Related]
9. Determination of common genetic variants in cytidine deaminase (CDA) gene in Indian ethnic population.
Iyer SN; Ankala A; Singhal RS; Hegde MR
Gene; 2013 Jul; 524(1):35-9. PubMed ID: 23612254
[TBL] [Abstract][Full Text] [Related]
10. High incidence of severe neutropenia after gemcitabine-based chemotherapy in Chinese cancer patients with CDA 79A>C mutation.
Xu J; Zhou Y; Zhang J; Chen Y; Zhuang R; Liu T; Cai W
Clin Chim Acta; 2012 Aug; 413(15-16):1284-7. PubMed ID: 22546611
[TBL] [Abstract][Full Text] [Related]
11. Pharmacokinetics of gemcitabine in Japanese cancer patients: the impact of a cytidine deaminase polymorphism.
Sugiyama E; Kaniwa N; Kim SR; Kikura-Hanajiri R; Hasegawa R; Maekawa K; Saito Y; Ozawa S; Sawada J; Kamatani N; Furuse J; Ishii H; Yoshida T; Ueno H; Okusaka T; Saijo N
J Clin Oncol; 2007 Jan; 25(1):32-42. PubMed ID: 17194903
[TBL] [Abstract][Full Text] [Related]
12. Ethnic differences of two non-synonymous single nucleotide polymorphisms in CDA gene.
Sugiyama E; Lee SJ; Lee SS; Kim WY; Kim SR; Tohkin M; Hasegawa R; Okuda H; Kawamoto M; Kamatani N; Sawada J; Kaniwa N; Saito Y; Shin JG
Drug Metab Pharmacokinet; 2009; 24(6):553-6. PubMed ID: 20045991
[TBL] [Abstract][Full Text] [Related]
13. Pharmacokinetics of gemcitabine in non-small-cell lung cancer patients: impact of the 79A>C cytidine deaminase polymorphism.
Maring JG; Wachters FM; Slijfer M; Maurer JM; Boezen HM; Uges DR; de Vries EG; Groen HJ
Eur J Clin Pharmacol; 2010 Jun; 66(6):611-7. PubMed ID: 20213492
[TBL] [Abstract][Full Text] [Related]
14. Cytidine deaminase polymorphisms and worse treatment response in normal karyotype AML.
Hyo Kim L; Sub Cheong H; Koh Y; Ahn KS; Lee C; Kim HL; Doo Shin H; Yoon SS
J Hum Genet; 2015 Dec; 60(12):749-54. PubMed ID: 26354033
[TBL] [Abstract][Full Text] [Related]
15. Cytidine deaminase polymorphism predicts toxicity of gemcitabine-based chemotherapy.
Ding X; Chen W; Fan H; Zhu B
Gene; 2015 Mar; 559(1):31-7. PubMed ID: 25582275
[TBL] [Abstract][Full Text] [Related]
16. Association of polymorphisms of cytosine arabinoside-metabolizing enzyme gene with therapeutic efficacy for acute myeloid leukemia.
Xu PP; Chen BA; Feng JF; Cheng L; Xia GH; Li YF; Qian J; Ding JH; Lu ZH; Wang XM; Xu K; Schultz M
Chin Med J (Engl); 2012 Jun; 125(12):2137-43. PubMed ID: 22884143
[TBL] [Abstract][Full Text] [Related]
17. Determinants of the interindividual variability in serum cytidine deaminase activity of patients with solid tumours.
Cohen R; Preta LH; Joste V; Curis E; Huillard O; Jouinot A; Narjoz C; Thomas-Schoemann A; Bellesoeur A; Tiako Meyo M; Quilichini J; Desaulle D; Nicolis I; Cessot A; Vidal M; Goldwasser F; Alexandre J; Blanchet B
Br J Clin Pharmacol; 2019 Jun; 85(6):1227-1238. PubMed ID: 30701582
[TBL] [Abstract][Full Text] [Related]
18. Correlation between cytidine deaminase genotype and gemcitabine deamination in blood samples.
Giovannetti E; Laan AC; Vasile E; Tibaldi C; Nannizzi S; Ricciardi S; Falcone A; Danesi R; Peters GJ
Nucleosides Nucleotides Nucleic Acids; 2008 Jun; 27(6):720-5. PubMed ID: 18600531
[TBL] [Abstract][Full Text] [Related]
19. Contribution of Cytidine Deaminase to Thymidylate Biosynthesis in Trypanosoma brucei: Intracellular Localization and Properties of the Enzyme.
Moro-Bulnes A; Castillo-Acosta VM; Valente M; Carrero-Lérida J; Pérez-Moreno G; Ruiz-Pérez LM; González-Pacanowska D
mSphere; 2019 Aug; 4(4):. PubMed ID: 31391279
[TBL] [Abstract][Full Text] [Related]
20. Effect of genetic alterations of cytarabine- metabolizing enzymes in childhood acute lymphoblastic leukemia.
Banklau C; Jindadamrongwech S; Sawangpanich R; Apibal S; Hongeng S; Paisooksantivatana K; Pakakasama S
Hematol Oncol Stem Cell Ther; 2010; 3(3):103-8. PubMed ID: 20890066
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
